Skip to content

Experimental and study design considerations for uncovering oncometabolites

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Metabolomics as a field has gained attention due to its potential for biomarker discovery, namely because it directly reflects disease phenotype and is the downstream effect of posttranslational modifications. The field provides a “top-down,” integrated view of biochemistry in complex organisms, as opposed to the traditional “bottom-up” approach that aims to analyze networks of interactions between genes, proteins and metabolites. It also allows for the detection of thousands of endogenous metabolites in various clinical biospecimens in a high-throughput manner, including tissue and biofluids such as blood and urine. Of note, because biological fluid samples can be collected relatively easily, the time-dependent fluctuations of metabolites can be readily studied in detail. In this chapter, we aim to provide an overview of (1) analytical methods that are currently employed in the field, and (2) study design concepts that should be considered prior to conducting high-throughput metabolomics studies. While widely applicable, the concepts presented here are namely applicable to highthroughput untargeted studies that aim to search for metabolite biomarkers that are associated with a particular human disease.

Cite

CITATION STYLE

APA

Haznadar, M., & Mathé, E. A. (2017). Experimental and study design considerations for uncovering oncometabolites. In Methods in Molecular Biology (Vol. 1513, pp. 37–47). Humana Press Inc. https://doi.org/10.1007/978-1-4939-6539-7_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free